Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture

NCT05883241 is registered in ClinicalTrials.gov with ZetrOZ, Inc. as lead sponsor.

NCT NCT05883241
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05883241 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustained Acoustic Medicine (SAM) for Symptomatic Treatment of Pain Related to Bone Fracture
Lead sponsor
ZetrOZ, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
June 1, 2023
Completion date
February 28, 2026
Enrollment
90 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

bone fracture, fresh fracture